[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BioTechHealthX](/creator/twitter/BioTechHealthX)
"$RMD With X billion people affected by sleep apnea @Resmed is positioned for explosive growth. See why ResMed is a smart long-term investment"  
[X Link](https://x.com/BioTechHealthX/status/1979794370871386257) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:18Z XXX followers, XX engagements


"$DRUG Trading near XXXX% of its 52-week high @brightmindsbio is poised for a major breakout backed by strong fundamentals"  
[X Link](https://x.com/BioTechHealthX/status/1979794979406086239) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:21Z XXX followers, XX engagements


"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"  
[X Link](https://x.com/BioTechHealthX/status/1973257534648754501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-01T05:23Z XXX followers, XXX engagements


"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"  
[X Link](https://x.com/BioTechHealthX/status/1976237900292661498) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T10:46Z XXX followers, XX engagements


"$BHST @bioharvest reports XX% annual revenue growth & a forecasted XX% yearly rise for the next X years far outpacing the XXX% industry average"  
[X Link](https://x.com/BioTechHealthX/status/1975613045062901974) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-07T17:23Z XXX followers, XX engagements


"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"  
[X Link](https://x.com/BioTechHealthX/status/1977421022988308755) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements


"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"  
[X Link](https://x.com/BioTechHealthX/status/1977421203972444385) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements


"$BMRN Multiple first-in-class therapies fuel consistent cash flow and long-term value for BioMarin Pharmaceutical. Learn about it more here"  
[X Link](https://x.com/BioTechHealthX/status/1979792565974208940) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:11Z XXX followers, XX engagements


"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"  
[X Link](https://x.com/BioTechHealthX/status/1976143068140347784) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:29Z XXX followers, XX engagements


"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"  
[X Link](https://x.com/BioTechHealthX/status/1978047322513871146) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:36Z XXX followers, XX engagements


"$DCTH High-margin model and strong cash position set stage for Delcath Systems' rapid commercial growth. Check this out"  
[X Link](https://x.com/BioTechHealthX/status/1979794493747646468) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:19Z XXX followers, XXX engagements


"$RKDA Arcadia Biosciences financial losses are accelerating despite its stock rally. Heres what Wall Street isnt telling you"  
[X Link](https://x.com/BioTechHealthX/status/1979795161954791501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:22Z XXX followers, XX engagements


"$SLS Late-stage trial momentum of SELLAS Life Sciences Group fuels buyout speculation from Wall Street. Check this out"  
[X Link](https://x.com/BioTechHealthX/status/1979799146459697432) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:37Z XXX followers, XXX engagements


"$AXSM @axsome reported $150M Q2 revenue with EPS of $XXXX vs $X expected. Strong Auvelity sales drove XX% YoY growth but net loss hit $48"  
[X Link](https://x.com/BioTechHealthX/status/1963968356140318748) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-09-05T14:11Z XXX followers, XXX engagements


"$SPRO Spero Therapeutics shares skyrocketed over XXX% after tebipenem HBr hit efficacy goals in a 1690-patient Phase X trial"  
[X Link](https://x.com/BioTechHealthX/status/1964744452632895645) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-09-07T17:35Z XXX followers, XXX engagements


"$CADL Analysts see Candel Therapeutics hitting $XXXXXXXX% higher than $5.39on viral immunotherapy breakthroughs led by CAN-2409 and CAN-3110"  
[X Link](https://x.com/BioTechHealthX/status/1976142701239337298) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:28Z XXX followers, XXX engagements


"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"  
[X Link](https://x.com/BioTechHealthX/status/1976143428372086932) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:31Z XXX followers, XXX engagements


"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"  
[X Link](https://x.com/BioTechHealthX/status/1976143799165624453) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:32Z XXX followers, XX engagements


"$EBS Down from $1B in prior years @EmergentLabsHQ's trailing twelve-month revenue exposes how hard its recovery journey has become"  
[X Link](https://x.com/BioTechHealthX/status/1976828927424528709) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-11T01:55Z XXX followers, XXX engagements


"$AXGN Revenue jumped XXXX% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to XX% upside before the December X ruling"  
[X Link](https://x.com/BioTechHealthX/status/1977420465649115281) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:05Z XXX followers, XX engagements


"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"  
[X Link](https://x.com/BioTechHealthX/status/1977804112512328114) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-13T18:30Z XXX followers, XXX engagements


"$GALT With belapectin showing a XX% reduction in varices @GalectinGALT targets a massive untapped market with no approved therapies"  
[X Link](https://x.com/BioTechHealthX/status/1977804258608349247) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-13T18:30Z XXX followers, XXX engagements


"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"  
[X Link](https://x.com/BioTechHealthX/status/1978047106062684517) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:35Z XXX followers, XX engagements


"$TNXP @TonixPharma shares fall despite FDA approval for Tonmya. Analysts say the sell-off could be a golden opportunity for long-term investors"  
[X Link](https://x.com/BioTechHealthX/status/1978047574411272323) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:37Z XXX followers, XXX engagements


"$CADL With $87.2M cash and $130M financing Candel Therapeutics is ready for its first Biologics License Application next year"  
[X Link](https://x.com/BioTechHealthX/status/1978440749445255501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-15T12:40Z XXX followers, XX engagements


"$SGHT @SightSciences jumps XX% in XX days with $XX billion glaucoma market exposureanalysts see accelerating revenue growth"  
[X Link](https://x.com/BioTechHealthX/status/1979799307621740714) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:38Z XXX followers, XX engagements